SYNTHOS RESEARCH

Deere & DE

Industrials · Agricultural - Machinery · Synthos Deep Dive · 2026-07-03

$621.27
Hold
Risk 6Growth 5Exponential 3Fair value $640 $470–$780

At a glance

VerdictHold — systematic Synthos tier
Price (2026-07-02)$621.27 · market cap ~$168B
Synthos scores (0–10)Downside Risk 6 · Growth Quality 5 · Exponential Potential 3
Synthos fair value (base case)~$640+3% · full range $470 (bear) – $780 (bull)
Street consensus$692 (high $812 / low $500; 18 Buy · 22 Hold · 6 Sell — "Hold") — context, not our anchor
Valuation35× trailing EPS · 34× FY26E · 27× FY27E · 23× FY28E · EV/S 4.8× · EV/EBITDA 19.5×
Exponential Potential3/10 · Low — mature, cyclical end-market; earnings are near a trough, not on an exponential ramp
TechnicalsUptrend but stretched — $621, −6.2% off 52-wk high, above 50/200-DMA, RSI 70 (at the overbought line)
ConvictionLow breadth — only 1 net-bullish voice / 8 reconciled claims; this is a fundamentals-and-quant call
Position sizingCyclical-quality satellite, ~1–3%, best added on downturn weakness — not near highs
Next catalyst2026-08-20 Q3 FY26 earnings (Street EPS $4.72)
Single biggest riskThe ag cycle: Large Ag guided down 15–20% in FY26; a deeper/longer trough resets earnings lower

One-line thesis. Deere is a genuinely elite industrial franchise — a widening precision-ag moat, ~18% ROE, a dealer-funded capital-light core — but the stock trades at 35× trailing EPS in the middle of an agricultural down-cycle (revenue already −26% from the FY23 peak, Large Ag guided down another 15–20%), so you are paying a premium multiple on depressed earnings for a recovery that has not yet arrived. Quality name, demanding entry: Watch.

◆ Synthos call — Hold DE is a solid business largely reflected at ~$640 — fine to keep, no reason to chase; it gets interesting again below ~$544.
Downside Risk (lower = safer)
6/10 · High
Low beta (0.93) & moat, but 35× trough EPS, deep ag downturn, and a captive-finance-heavy balance sheet.
Growth Quality
5/10 · Moderate
High-quality ~18% ROE compounder, but revenue down ~26% from the 2023 peak; cyclically depressed, not secularly growing.
Exponential Potential
3/10 · Low
Precision-ag optionality is real, but a $168B cap in a mature, cyclical end-market caps the multibagger.
⚖ Reverse-DCF cross-check Market-implied growth ≈ 22%/yr To justify today’s $621, earnings would have to compound roughly 22% a year for 10 years (9% discount rate). Analysts forecast ~6%/yr, so the market is pricing in MORE than what the Street expects.
What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.

In plain English

Deere makes the big green tractors, combines, and construction machines — the John Deere equipment you see on farms and job sites. It is the best in the world at it, and increasingly sells precision-farming technology (GPS, sensors, self-driving equipment) that makes farmers more productive and keeps them coming back.

The catch: farming is cyclical. When crop prices are low, farmers stop buying new equipment, and Deere's sales fall. That is happening right now — sales are down about a quarter from their 2023 peak, and management expects big-tractor demand to fall another 15–20% this year. Yet the stock is expensive (about 35× earnings), because investors are paying today for the recovery they expect later.

Our verdict is Watch — a great company, but not at this price and this point in the cycle. The smart move is to keep it on the list and buy on weakness, not chase it near its highs.

Here's what our three scores mean in everyday terms:

The one big worry: the farm economy. If low crop prices and high interest rates keep farmers from buying, this down-cycle could go deeper and last longer than expected, and the earnings the stock is priced on would fall further.


Price & moving averages 12 months · 50 & 200-day averages · 52-week range

421486551616680Jul '25Sep '25Nov '25Feb '26Apr '26Jul '2652w hi $662Price 62150-DMA 578200-DMA 53452w lo $439

Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.

Bollinger Bands 20-day average ± 2 standard deviations

420489558627696Jul '25Sep '25Nov '25Feb '26Apr '26Jul '26Price 62120-day avg 596

The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.

RSI (14) momentum gauge · 0–100

705030Jul '25Sep '25Nov '25Feb '26Apr '26Jul '26RSI 60.7

Above 70 (red band) = overbought, below 30 (green band) = oversold. Currently 61.

MACD 12 / 26 / 9 · trend & momentum

0Jul '25Sep '25Nov '25Feb '26Apr '26Jul '26MACD 15.4signal 11.6

Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.

Relative performance vs S&P 500 & its sector (XLI (sector)), set to 100 a year ago

8193106118131Jul '25Sep '25Nov '25Feb '26Apr '26Jul '26XLI (sector) 124S&P 500 120DE 119

Solid = DE · dashed = S&P 500 · dotted = XLI (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.

Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate

017335066$40BFY21EPS $19$47BFY22EPS $23$59BFY23EPS $33$45BFY24EPS $25$38BFY25EPS $18$42BFY26EEPS $18$45BFY27EEPS $23$49BFY28EEPS $27

Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.

Key stats an RIA wants

Price$621.27
Market cap$168B
P/E trailing27×
P/E FY26E / FY27E34× / 27×
EV / Sales4.8×
EV / EBITDA19.5×
Gross margin35.4%
Net margin10.2%
Dividend yield1.04%
Beta0.928
52-wk range$439 – $662
RSI(14)70
50 / 200-DMA$578 / $534
12-mo return+22% (SPY +21%)
Street target$692 ($500–$812)
Analyst grades18 Buy · 22 Hold · 6 Sell
FMP ratingB-
Next earnings2026-08-05

What the experts actually said 8 traceable claims on DE · showing the highest-conviction voices

“Deere is the key enabler of low-cost global food with a widening competitive advantage in industrial agriculture equipment.”
Business Breakdownsbullishconviction 852023-05-18business_breakdowns-X7NLN-8mAAI:e13bcc01db
“Deere offloads capital/inventory intensity to dealers, runs ~25-30% gross margin, low-to-mid-teens net on the AG business at $20-28B revenue.”
Business Breakdownsneutralconviction 702023-05-18business_breakdowns-X7NLN-8mAAI:d73861597d

Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.

1. What it is

Deere & Company (NYSE: DE), founded 1837 and headquartered in Moline, Illinois, is the world's largest maker of agricultural equipment and a major producer of construction, forestry, and turf machinery, with a captive finance arm that funds dealers and end-customers. Fiscal year ends late October / early November.

Four reported segments: Production & Precision Agriculture (PPA) — large tractors, combines, sprayers, and the precision-ag tech stack; Small Agriculture & Turf (SAT) — utility tractors, mowers, turf; Construction & Forestry (CF) — earthmoving, roadbuilding, logging; and Financial Services — dealer/retail financing.

Revenue mix (FY2025, from filings):

The structural story the one bullish KB voice keeps returning to: Deere is the key enabler of low-cost global food, and its precision-ag technology (guidance, See & Spray, autonomy, connected machines) is widening the moat and shifting the model toward recurring, software-like revenue over time.

2. The expert thesis — thin KB, so this is a fundamentals call (traceable)

Honesty note first: Synthos KB coverage on DE is thin — 8 total claims, only 1 net-bullish voice, and the most recent claim is dated 2023-05-18. This is not a high-conviction, broad-panel name like our flagship healthcare picks. The verdict below is fundamentals- and quant-driven; the expert layer is corroborating color, not the anchor.

What the KB does contain (both from the Business Breakdowns podcast panel, skill 1.0):

Honest composite note. With one net-bullish voice and a 2023-vintage last claim, the KB is too thin to carry a conviction rating. It corroborates the quality/moat half of the story; it says nothing current about valuation or the present down-cycle. We therefore lean on the financials and estimates below, and we score accordingly.

3. Synthos scores & the Bull / Base / Bear cases

The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):

Score0–10The read
Downside Risk (lower = safer)6 · Moderate-HighBeta 0.93 and a real moat cushion, but 35× trough EPS + a deepening ag downturn + gross debt $64B (captive-finance-heavy) leaves little margin if the recovery slips.
Growth Quality5 · AverageElite franchise — ~18% ROE, ~35% gross margin, dealer-funded capital-light core — but revenue is down ~26% from the FY23 peak and still falling. Quality is high; current growth is negative.
Exponential Potential3 · LowPrecision-ag/autonomy optionality is genuine, but a $168B cap in a mature, cyclical end-market with decelerating (trough) earnings caps the multibagger. This is a compounder, not an exponential.

The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. Instead the cases bound the range, and the scores above summarize them.

CaseKey assumptionsFair value
BullAg cycle troughs in FY26 and turns; crop prices firm, farmer sentiment recovers. FY28E EPS beats toward ~$30 (vs $27.3 cons) on operating leverage; market pays a mid-cycle ~26×.~$780 (+26%)
Base (our anchor)Downturn plays out as guided (Large Ag −15–20% FY26), then a normal recovery. FY27E EPS ~$22.7; a through-cycle ~28× on trough-plus-one earnings.~$640 (+3%)
BearDown-cycle deepens/extends — crop prices stay weak, high rates crimp financing, tariffs bite. FY26 EPS lands near the mgmt-guide low (~$16.7) and FY27 fails to recover; multiple de-rates to ~22× on ~$21 EPS.~$470 (−24%)

Synthos fair value = the base case, ~$640 (+3%), with the full $470–$780 span as the honest range. Our base sits below the Street's $692 consensus — we are less willing to pay up for a recovery still on the come, mid-downturn. The Street's own range ($500–$812) brackets a similar spread; the split is the classic quality-vs-cycle debate. This is a tracked call — the Forecaster Scorecard grades it once it matures.

4. Exponential Potential

Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). DE is a high-quality cyclical compounder — decidedly not an exponential:

Exponential Potential: Low (3/10). Own DE for through-cycle quality compounding and a widening moat, bought at the right point in the cycle — not for a fast multibagger. A small, accelerating precision-ag pure-play would score far higher; Deere is the incumbent, not the disruptor.

5. Financials (real numbers — FMP annual/quarterly)

6. Valuation — priced in or room?

Hard to call DE cheap here. 35× trailing EPS, 4.8× EV/sales, 19.5× EV/EBITDA — and, critically, that 35× is on cyclically depressed earnings, which makes the "expensive" read worse, not better (high P/E on trough EPS is the classic late-downturn trap). On forward consensus the multiple compresses only as the recovery arrives: 34× (FY26E) → 27× (FY27E) → 23× (FY28E). The bull's defense is that FY26 is the trough and normalized mid-cycle EPS is well above today's — but you are paying today for that normalization. FMP's letter grade is B− (overall score 2/5; P/E and debt-to-equity both scored 1/5), and the DCF component scored a modest 3/5 — quant models see the same richness we do. Street targets (context): consensus $692, high $812, low $500, grades 18 Buy / 22 Hold / 6 Sell ("Hold"). Our ~$640 base is below consensus — we won't underwrite the full recovery at a premium multiple mid-cycle. Not a value entry; a quality-at-a-full-price, wait-for-the-cycle name.

7. Technicals (from the tech block)

8. Moat & competitive position

Deere's moat is one of the widest in industrials: (1) brand + dealer network — an unmatched North American dealer footprint that is both a distribution moat and, per the KB, an inventory/capital sponge that lifts returns on capital; (2) precision-ag technology leadership — guidance, See & Spray, autonomy, and the JDLink connected-machine data layer, a growing switching-cost/recurring-revenue engine that rivals can't easily match; (3) scale in R&D (~$2.3B/yr) and manufacturing. The direct ag comps are CNH Industrial, AGCO, and Kubota; Caterpillar overlaps in construction. Deere out-earns and out-invests all of them.

Peer set (FMP-supplied industrial comps, market cap): Union Pacific $168B, Eaton $155B, Lockheed Martin $126B, Parker-Hannifin $121B, General Dynamics $101B, Automatic Data Processing $97B, Illinois Tool Works $78B, Northrop Grumman $78B, Honeywell $73B, PACCAR $63B. (Note: FMP's peer list is broad-industrials, not pure ag-equipment — the truest comps, CNH/AGCO/Kubota, are not in it. Treat this list as sector context, not a like-for-like valuation set.) Deere's ~18% ROE and precision-ag franchise justify a premium within industrials — the debate is purely about cyclical timing, not franchise quality.

9. Management, capital allocation & guidance

10. Catalysts & what to watch

Thesis tripwires (what would change the call): a cut to the full-year guide (trough deeper than guided); two more quarters of PPA order deterioration; crop prices making new lows; or, conversely, an up-cycle inflection (rising orders + firming crop prices) that would move this from Watch toward Buy.

11. Key risks

12. Verdict, position sizing & monitoring

Watch. Deere is a genuinely elite industrial franchise — ~18% ROE, a widening precision-ag moat, disciplined counter-cyclical capital allocation, and diversification (Small Ag/Turf and Construction) actively cushioning the ag trough. But the stock trades at 35× trailing / 34× FY26E EPS on cyclically depressed earnings, mid-downturn, with RSI at 70 and price near its highs — you are paying a premium for a recovery that has not yet shown up in the order books. The quality is not in question; the entry price and cycle timing are. Our base-case fair value (~$640) sits below the Street's $692, and the honest range ($470–$780) is wide because it is a cycle call.


Provenance & disclosures